Trematode Infections: Clinical Trials

19 trials for Trematode Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 4 unknown, 2 not yet recruiting. 19 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 219Completed 13, Unknown 4, Not yet recruiting 2
Phase 34Completed 3, Not yet recruiting 1
Phase 12Completed 1, Unknown 1

Follow Trematode Infections: new trials by email Literature Review of Trematode Infections trials Research Report on Trematode Infections

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis
Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni
Phase 2 / Phase 3Not yet recruitingRhode Island Hospital6002026-11-012026-08-12
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
Oxfendazole, Triclabendazole - Fascioliasis
Phase 2Not yet recruitingUniversidad Peruana Cayetano Heredia3362026-08-152026-06-03
Sm-p80 Schistosomiasis Challenge Study
Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis
Phase 2UnknownLeiden University Medical Center482024-09-012023-10-17
Anti-Schistosomiasis Sm14-vaccine in Senegal
Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium
Phase 2UnknownOswaldo Cruz Foundation1202022-07-012022-12-21
Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni
Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni
Phase 2 / Phase 3CompletedKenya Medical Research Institute4002021-05-062022-07-12
Praziquantel in Children Under Age 4
Praziquantel - Schistosomiasis, Schistosomiasis Mansoni
Phase 2CompletedRhode Island Hospital3542021-02-012026-04-23
Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension
Selexipag - Pulmonary Hypertension, Schistosomiasis
Phase 2UnknownUniversity of Sao Paulo General Hospital202020-10-152020-10-19
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine - Schistosomiasis, Schistosoma Mansoni
Phase 1 / Phase 2CompletedBaylor College of Medicine2902019-10-072025-11-04
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
Praziquantel 600Mg Oral Tablet x 5, Praziquantel 600Mg Oral Tablet x 1 - Schistosomiasis
Phase 2 / Phase 3CompletedRegionshospital Nordjylland1162019-09-032020-05-18
Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children
Sm14, GLA-SE solution - Schistosomiasis
Phase 2CompletedOswaldo Cruz Foundation952018-12-132019-12-09
Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection
Artesunate-Pyronaridine, Artemether-Lumefantrine, Artefenomel-Ferroquine - Schistosomiasis Haematobia
Phase 2CompletedCentre de Recherche Médicale de Lambaréné542018-07-312020-02-11
Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions
Sm14, GLA-SE solution - Schistosomiasis
Phase 2CompletedOswaldo Cruz Foundation302016-12-062017-12-14
An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)
Biltricide (racemate praziquantel) oral tablets, Racemate Praziquantel ODT, Levo Praziquantel ODT - Schistosomiasis
Phase 2CompletedMerck KGaA, Darmstadt, Germany4442016-06-122019-11-20
Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation
Phase 1 / Phase 2UnknownResearch Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan3002015-01-012023-03-03
Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents
MVA85A - Tuberculosis
Phase 2CompletedUniversity of Oxford362014-06-012015-01-30
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
Praziquantel - Intestinal Schistosomiasis
Phase 2CompletedMakerere University8002012-12-012014-09-17
Activity of Mefloquine Against Urinary Schistosomiasis
Mefloquine, S/P - Urinary Schistosomiasis
Phase 2CompletedAlbert Schweitzer Hospital652010-05-012013-01-24
S. Japonicum and Pregnancy Outcomes
Praziquantel, Placebo - Schistosomiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3702007-08-012016-01-26
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Artesunate+Sulfamethoxypyrazine/pyrimethamin, Praziquantel - Schistosoma Haematobium
Phase 2 / Phase 3CompletedDafra Pharma8002007-08-012008-01-18

Narrower conditions

Schistosomiasis (13)  ·  Schistosomiasis haematobia (4)  ·  Schistosomiasis mansoni (3)  ·  Schistosomiasis japonica (2)  ·  Colitis, Ulcerative (1)  ·  Fascioliasis (1)  ·  Hypertension, Portal (1)  ·  Hypertension, Pulmonary (1)  ·  Infections (1)  ·  Liver Cirrhosis (1)  ·  Protozoan Infections (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Tuberculosis (1)

Broader conditions

Helminthiasis (19)  ·  Parasitic Diseases (19)  ·  Infections (18)  ·  Vector Borne Diseases (17)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Schistosomiasis (4)  ·  Urinary Tract Infections (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Digestive System Diseases (3)  ·  Liver Diseases (2)  ·  Actinomycetales Infections (1)

Interventions

Praziquantel (8)  ·  SM14 protein, Schistosoma mansoni (2)  ·  glucopyranosyl lipid-A (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  MVA 85A (1)  ·  Mefloquine (1)  ·  Mesalamine (1)  ·  Tablets (1)  ·  Triclabendazole (1)  ·  nitazoxanide (1)  ·  oxfendazole (1)  ·  pyronaridine tetraphosphate, artesunate drug combination (1)  ·  selexipag (1)

Sponsors

Oswaldo Cruz Foundation (3)  ·  Rhode Island Hospital (2)  ·  Albert Schweitzer Hospital (1)  ·  Baylor College of Medicine (1)  ·  Centre de Recherche Médicale de Lambaréné (1)  ·  Dafra Pharma (1)  ·  Kenya Medical Research Institute (1)  ·  Leiden University Medical Center (1)  ·  Makerere University (1)  ·  Merck KGaA, Darmstadt, Germany (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Regionshospital Nordjylland (1)  ·  Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1)  ·  Universidad Peruana Cayetano Heredia (1)  ·  University of Oxford (1)

Countries

Uganda (5)  ·  Senegal (3)  ·  Gabon (2)  ·  Brazil (1)  ·  Germany (1)  ·  Kenya (1)  ·  Madagascar (1)  ·  Mali (1)  ·  Philippines (1)  ·  United Kingdom (1)

Top investigators

Miriam Tendler, MD, PhD (2)  ·  Alison Elliot (1)  ·  Allen Nalugwa, PhD (1)  ·  Annette Olsen, PhD (1)  ·  Bodo S Randrianasolo, MD (1)  ·  Caio J Fernandes, PHD (1)  ·  Edridah Muheki, PhD (1)  ·  Elijah M Songok, PhD (1)  ·  Fred Nuwaha, PhD (1)  ·  Hannah Kibuuka, MD (1)  ·  Hector H Garcia, MD PhD (1)

Results publications

PMID 19150418, PMID 2022660, PMID 21298114, PMID 23284726, PMID 26571311, PMID 33998661, PMID 19802383, PMID 23175561, PMID 26511959, PMID 27441564, PMID 28472067, PMID 29546300, PMID 30469320, PMID 30687792, PMID 31188820, PMID 33188747, PMID 33861768, PMID 35788749, PMID 36315579, PMID 36342912, PMID 40412398

NIH funding

R01AI184979 (1), R01HD095562 (1), U01AI155323 (1)